Search

How will Imperial College London's newly floated tech-transfer affiliate invest its stock-market millions? After raising the money, now comes the fun part: spending it.

Biotech start-ups in France and elsewhere in Europe make a unique and important contribution to healthcare. They merit special treatment to help them grow.

We applaud a rare bout of honesty.

The technology-transfer unit of Imperial College London, continuing preparations for its stock-market debut on 31 July, said it has completed a £25 million private placement and set a public share price that would value the business at £181 million.

The stock-market debut at the end of July of Imperial College London’s tech-transfer office is the best news for academic reform in years.

The academic community is in the middle of a massive debate on how people should be able to access the results of publicly funded research.

Imperial College London is set to become the first university to float its technology-transfer office directly on the stock market.

SMEs across Europe are backing to Framework Programme 7 - provided it avoids the funding pitfalls that emerged over the life of its predecessor.

This week the European Investment Fund took the first step in its ambitious new plan to unleash a wave of technology transfer across Europe. In doing so it endorsed a model pioneered in the UK.

French researchers have developed a cell therapy that could slash the risk of rejection after bone marrow grafts to under 5 per cent, and are looking for first-round funding.

India's failure to launch a functional communications satellite using a home-grown rocket is likely to spur even more investment in space programmes.

A key distinction between physical and intellectual property is that the value of the latter is created as much by sharing it as by owning it. How to share it, between creator and enabler, is a particularly acute issue within the academic environment - as indicated by a recent, noteworthy debate on the subject in Sweden.

TeGenero, the company behind the drug trial fiasco that put six healthy volunteers into intensive care, has announced it is filing for insolvency.

Finland wants to use its six months presiding over the EU to change innovation policy. It picks up the gauntlet at a meeting of competition ministers next week.

Germany's academic spin-outs are not such a force for developing the economy after all, according to an in depth study of 20 of their number.

The Health Research Board of Ireland is to join the consortium of UK research funders developing a single gateway to the largest pool of patients in the world.

As the European Commission ponders the single European patent, the European Patent Office is under attack from national patent offices that want some of its functions.

Innovation will be a priority for the EU over the next six months

The claim that European public opinion contributes to the technology gap between the US and Europe is invalid, according to the latest Eurobarometer survey.

It's better to have fewer, stronger, spin-offs than shoals of tiddlers, as Marina Murphy discovers.